Lixil Group Corporation (5938):企業の財務・戦略的SWOT分析

◆英語タイトル:Lixil Group Corporation (5938) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8012382
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月5日
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:建設・不動産
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Lixil Group Corporation (5938) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Lixil Group Corporation (Lixil) operates housing and building materials, products and services business. The company manufactures and sells a range of housing and living-related products such as windows and interior and exterior building materials, tiles, entrance doors and interior fabrics to larger systems such as unit bathrooms, Washstands, toilets and kitchens. It also offers services such as real estate franchising, housing loans and real estate management. The company offers products and services under various brands, namely, Lixil VIVA, Lixil Energy, Jaxon, American Standards, Asahi Tostem, INAX and Permasteelisa. It caters to dealers, developers, wholesalers, construction companies, retailers, architectural firms and general consumers. The company has its presence in the Americas, Europe, the Middle East and Africa, and Asia Pacific. Lixil is headquartered in Chiyoda-ku, Tokyo, Japan.

Lixil Group Corporation Key Recent Developments

Aug 07,2017: LIXIL records increased revenue and core earnings in Q1
May 08,2017: LIXIL announces record high net profit for FYE2017
Feb 08,2017: Chris Brown appointed chief sales officer for LIXIL Americas
Feb 06,2017: LIXIL Q3 core earnings increases 9% to 73.8 billion Yen
Nov 07,2016: LIXIL H1 net profit rises to 24.1 billion yen

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Lixil Group Corporation – Key Facts 5
Lixil Group Corporation – Key Employees 6
Lixil Group Corporation – Key Employee Biographies 7
Lixil Group Corporation – Major Products and Services 8
Lixil Group Corporation – History 9
Lixil Group Corporation – Company Statement 12
Lixil Group Corporation – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 16
Lixil Group Corporation – Business Description 16
Lixil Group Corporation – Corporate Strategy 17
Lixil Group Corporation – SWOT Analysis 18
SWOT Analysis – Overview 18
Lixil Group Corporation – Strengths 18
Lixil Group Corporation – Weaknesses 19
Lixil Group Corporation – Opportunities 20
Lixil Group Corporation – Threats 21
Lixil Group Corporation – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios – Interim Ratios 28
Financial Ratios – Ratio Charts 29
Lixil Group Corporation, Recent Deals Summary 30
Section 4 – Company’s Recent Developments 31
Aug 07, 2017: LIXIL records increased revenue and core earnings in Q1 31
May 08, 2017: LIXIL announces record high net profit for FYE2017 32
May 08, 2017: LIXIL announces record high net profit for FYE2017 34
Feb 06, 2017: LIXIL Q3 core earnings increases 9% to 73.8 billion Yen 36
Nov 07, 2016: LIXIL H1 net profit rises to 24.1 billion yen 38
Oct 11, 2016: Troy Benavidez named vice president, public affairs of LIXIL Water Technology Americas 40
Oct 11, 2016: Jill Albanese appointed chief human resources officer of LIXIL Water Technology Americas 41
Mar 07, 2016: LIXIL Strengthens Management of Overseas Businesses with Organization Changes in Water Technology 42
Section 5 – Appendix 43
Methodology 43
Ratio Definitions 43
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Lixil Group Corporation, Key Facts 5
Lixil Group Corporation, Key Employees 6
Lixil Group Corporation, Key Employee Biographies 7
Lixil Group Corporation, Major Products and Services 8
Lixil Group Corporation, History 9
Lixil Group Corporation, Other Locations 14
Lixil Group Corporation, Subsidiaries 14
Lixil Group Corporation, Key Competitors 22
Lixil Group Corporation, Ratios based on current share price 23
Lixil Group Corporation, Annual Ratios 24
Lixil Group Corporation, Annual Ratios (Cont...1) 25
Lixil Group Corporation, Annual Ratios (Cont...2) 26
Lixil Group Corporation, Interim Ratios 28
Lixil Group Corporation, Recent Deals Summary 30
Currency Codes 43
Capital Market Ratios 43
Equity Ratios 44
Profitability Ratios 44
Cost Ratios 45
Liquidity Ratios 45
Leverage Ratios 46
Efficiency Ratios 46

★海外企業調査レポート[Lixil Group Corporation (5938):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Phillips 66 Co (PSX):石油・ガス:M&Aディール及び事業提携情報
    Summary Phillips 66 Co (Phillips 66) is a diversified energy manufacturing and logistics company. It gathers, processes, transports, stores and markets natural gas and petroleum products such as gasoline, diesel, aviation fuel and lubricants. It also transports, fractionates and markets natural gas …
  • Samba Financial Group (1090):企業の財務・戦略的SWOT分析
    Samba Financial Group (1090) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Omeros Corp (OMER):製薬・医療:M&Aディール及び事業提携情報
    Summary Omeros Corp (Omeros) is a biopharmaceutical company that discovers, develops and commercializes small-molecule and protein therapeutics for large-market and orphan indications. The company’s pipeline products include Omidria, a phenylephrine and ketorolac injection for use during cataract su …
  • Smiths Medical-医療機器分野:企業M&A・提携分析
    Summary Smiths Medical, a division of Smiths Group Plc, is a clinically-focused company, which manufactures medical devices used in various therapeutic, diagnostic and surgical procedures with focus on vital care, safety devices and medication delivery areas. The company’s product line consists of a …
  • VeriSign Inc (VRSN):企業の財務・戦略的SWOT分析
    VeriSign Inc (VRSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Casio Computer Co Ltd (6952):企業の財務・戦略的SWOT分析
    Casio Computer Co Ltd (6952) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Efore Oyj (EFO1V):企業の財務・戦略的SWOT分析
    Efore Oyj (EFO1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Hyundai Heavy Industries Co Ltd (009540):電力:M&Aディール及び事業提携情報
    Summary Hyundai Heavy Industries Co Ltd (HHI) is one of the leading shipbuilding companies in the world. HHI manufactures VLCCs, containerships, P/C ships, LNG carriers, and warships. Its offering also includes combined cycle power plant, thermal power plant, oil and gas processing plant, LNG plant, …
  • First Pacific Co Ltd (142):企業の財務・戦略的SWOT分析
    First Pacific Co Ltd (142) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • EyePoint Pharmaceuticals Inc (PSDV):企業の製品パイプライン分析2018
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …
  • CoreRx Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CoreRx Inc (CoreRx) is a contract development manufacturing organization that provides a comprehensive range of drug development services. The company provides products portfolio such as oral, topical, liquids or parental, ophthalmic and combined medicines, among others. It provides a wide r …
  • PTB Group Limited:企業の戦略・SWOT・財務情報
    PTB Group Limited - Strategy, SWOT and Corporate Finance Report Summary PTB Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mitsubishi International Food Ingredients, Inc.:戦略・SWOT・企業財務分析
    Mitsubishi International Food Ingredients, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi International Food Ingredients, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • MicroVention Inc:製品パイプライン分析
    Summary MicroVention Inc (MicroVention), a subsidiary of Terumo Corp is a medical device company that develops catheter based technologies for the endovascular treatment of peripheral and cerebral vascular diseases. The company offers products such as platinum coils, hydrogel coils, delivery and det …
  • Pernix Therapeutics Holdings Inc (PTX)-医療機器分野:企業M&A・提携分析
    Summary Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that provides generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR) opioid agonist that is …
  • TOWER Limited:企業の戦略・SWOT・財務情報
    TOWER Limited - Strategy, SWOT and Corporate Finance Report Summary TOWER Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Wesfarmers Limited:企業の戦略・SWOT・財務情報
    Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report Summary Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • BioMarin Pharmaceutical Inc (BMRN):企業の財務・戦略的SWOT分析
    BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Piramal Glass Pvt Ltd:企業の戦略・SWOT・財務情報
    Piramal Glass Pvt Ltd - Strategy, SWOT and Corporate Finance Report Summary Piramal Glass Pvt Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆